4/22 Best Idea For The Week Ahead

$115B co looks set to run

We have a $115B defensive healthcare name paying a 3%+ dividend that has quietly been outperforming recently after a long period of underperformance, and it is finally breaking out. Last year healthcare names broke out as the market declined, is this telling us something with the post I made yesterday about the weak internals of the market?

The name is still nearly 40% off its 2021 highs and it finally looks like it is about to run after reclaiming the 200 day this week. This is going to be a great long term buy at these levels in my opinion for those interested in that. I’m going to show you the charts, show you the options flows, the dividend growth for those looking for a longer hold, and more. Afterwards I will discuss how I would play it. If you have any questions be sure to leave them in the comment section at the bottom, let’s dive into it.